La Roche Posay Laboratoire Dermatologique Effaclar Clarifying Solution
NDC Package 49967-024-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

La Roche Posay Laboratoire Dermatologique Effaclar Clarifying (salicylic acid) solution is a medication used on the skin to treat common skin and foot (plantar) warts. This formulation utilizes a solution delivery system. Marketed by L'oreal Usa Products Inc, this product is identified by NDC 49967-024 and is authorized under FDA application M006.

Identification & Billing

NDC Package Code
49967-024-01
Package Description
200 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
49967002401
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
La Roche Posay Laboratoire Dermatologique Effaclar Clarifying
Non-Proprietary Name
Salicylic Acid
Substance Name
Salicylic Acid
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.

Regulatory & Marketing

Labeler Name
L'oreal Usa Products Inc
Product Type
Human Otc Drug
FDA Application #
M006
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-01-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (49967-024). Click a package code to view its specific billing and regulatory data.

100 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49967-024-01 identifies a specific commercial package of 200 ml in 1 bottle of La Roche Posay Laboratoire Dermatologique Effaclar Clarifying, a human over the counter drug labeled by L'oreal Usa Products Inc. This solution is formulated for topical use and contains salicylic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by L'oreal Usa Products Inc on August 01, 2014. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.

How is this L'oreal Usa Products Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49967002401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49967-024-01
11-Digit CMS (5-4-2)
49967-0024-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.